Liver Cancer Bibliography

A select reference list of the more relevant papers on interventional radiology treatments for liver cancer

  1. Salem R, Lewandowski R, Mulcahy M, Riaz A, Ryu R, Ibrahim S, Atassi B, Baker T, Gates V, Miller F, Sato K, Wang E, Gupta R, Benson A, Newman S, Omary R, Abecassis M, Kulik L. Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes. Gastroenterology 2010; Volume 138, Issue 1: 52-64.
  2. Riaz A, Ryu R, Kulik L, Mulcahy M, Lewandowski R, Minocha J, Ibrahim S, Sato K, Baker T, Miller F, Newman S, Omary R, Abecassis M, Benson A, Salem R. Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression and Survival. J. Clin. Oncol. 27: 5734-5742.
  3. Min-Shan Chen, Jin-Qing Li, et al. A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma. Annals of Surgery. 2006;3:321–328.
  4. Mayo-Smith WW, Dupuy DE. Adrenal neoplasms: CT-guided radiofrequency ablation-preliminary results. Radiology 2004; 231:225-30.
  5. Shi M, Zhang CQ, Zhang YQ, et al. Micrometastasis of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg . 2004;28:376–381.
  6. Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M, Courtney. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc and Interv Radiol 2004; 15:335-334.
  7. Carr BI. Hepatic arterial 90Yttrium glass microspheres for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004; 10(suppl 2):S107-10
  8. Lau WY, Leung TW, Yu SC, et al. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg . 2003;237:171–179.
  9. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. Am J Radiol 2003; 180:1503-8.
  10. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radiofrequency ablation of 42 tumors. Radiology 2003; 226:417-424.
  11. Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003; 97:554-560.
  12. Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Beres R, Regge D. Percutaneous CT/US-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. Radiology 2002; 225(P):163. (abstract. Full publication in J Clin Oncol 2003, in press).
  13. Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable primary liver cancer. J Am Coll Surg 2002; 194:813-828.
  14. Dupuy DE, Mayo-Smith WW, Abbott G, DiPetrillo T. Clinical applications of radiofrequency tumor ablation in the thorax. Radiographics 2002; Spec No:S259-69.
  15. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb . 2002;47:389 –399.
  16. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 2001; 130:971-977.
  17. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 2001; 5:294-302.
  18. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 2 21:159-166.
  19. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol . 2001;11:914 –921.
  20. Olschewski M, Lencioni R, Allgaier H, et al. A randomized comparison of radiofrequency thermal ablation and percutaneous ethanol injection for the treatment of small hepatocellular carcinoma [Abstract]. Proc Am Soc Clin Oncol. 2001:500.
  21. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona 2000 EASL Conference. European Association for the Study of the Liver. J Hepatol . 2001;35:421– 430.
  22. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology . 2001;34:707–713.
  23. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology . 2000;32:1224 –1229.
  24. de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am J Radiol 2000; 175:1619-1625.
  25. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular carcinoma in 110 patients with cirrhosis. Ann Surg . 2000;232: 381–391.
  26. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231unresectable hepatic tumors: indications, limitations and complications. Ann Surg Oncol . 2000;7:593– 600.
  27. Nicoli N, Casari A, Marchiori L, et al. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma. Chir Ital . 2000;52:29–40.
  28. Shiina S, Teratani T, Obi S, et al. Prospective randomized controlled trial comparing percutaneous radio-frequency ablation and percutaneous ethanol injection therapy for small hepatocellular carcinoma. Gastroenterology . 2000;118(suppl):959.
  29. Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis . 1999;19:271–285.
  30. Lencioni RA, Cioni D, Donati F, et al. Percutaneous treatment of small hepatocellular carcinoma in cirrhosis: radiofrequency thermal ablation vs ethanol injection a prospective, randomized trial (final report). Radiology . 1999;213(suppl):123.
  31. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med . 1999;340:745–750.
  32. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol . 1998;170:1015–1022.
  33. Taylor-Robinson SD, Foster GR, Arora S, et al. Increase in primary liver cancer in the UK 1979–94. Lancet . 1997;350:1142–1143.
  34. Lai EC, Fan ST, Lo CM, et al. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg . 1995;221:291–298.
  35. Isobe H, Sakai H, Imari Y, et al. Intratumor ethanol injection therapy for solitary minute hepatocellular carcinoma: a study of 37 patients. J Clin Gastroenterol . 1994;18:122–126.
  36. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology . 1993;18:1121–1126.
  37. Shiina S, Tagawa N, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol . 1993;60:1023–1028.
  38. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer . 1992;69:925–929.
  39. Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer . 1980;45:2663–2669.